REQUEST A DEMO
Total
USD $0.00
Search more companies

Ad Biotech Co.,Ltd. (South Korea)

Main Activities: Other Animal Food Manufacturing
Full name: Ad Biotech Co.,Ltd. Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company is a Korea-based company principally engaged in the manufacture and sale of veterinary drugs. The products consist of antibiotics, metabolic drugs, anthelmintics, disinfectants, supplement feed, feed additives, and others. The Company also produces functional foods, cosmetics, among others. The Company was founded on June 20, 2000 and its shares are listed on KOREA NEW EXCHANGE(KONEX) on December 24, 2019.

Headquarters
39 Daegeo Complex 1-Gil, Dongnae-Myeon, Chuncheon-Si, Gangwon-Do
Chuncheon; Gangwon;

Contact Details: Purchase the Ad Biotech Co.,Ltd. report to view the information.

Website: http://www.adbiotech.com

Basic Information
Total Employees:
Purchase the Ad Biotech Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Ad Biotech Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Ad Biotech Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Ad Biotech Co.,Ltd. report to view the information.
Incorporation Date:
June 20, 2000
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Subsidiaries
㈜애드바이오텍
Company Performance
Financial values in the chart are available after Ad Biotech Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-1.5%
Total operating revenue
-1.45%
Operating profit (EBIT)
-52.53%
EBITDA
13.99%
Net Profit (Loss) for the Period
N/A
Total assets
-9.43%
Total equity
-32.98%
Operating Profit Margin (ROS)
-26.05%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
46.57%
Quick Ratio
-0.09%
Cash Ratio
0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?